CMP Pharma and Kiel Laboratories have signed an agreement to develop and commercialize two new drug products. Both drugs are approved by the FDA in solid dosage forms and CMP will file NDAs to gain approval for an alternate liquid dosage form.
 
CMP Pharma is a specialty pharmaceutical company located in Farmville, NC that develops and manufactures a portfolio of high-value topical and liquid pharmaceutical products. Kiel Laboratories, Inc., located in Flowery Branch, GA, provides drug development, regulatory and intellectual property services, and specializes in identification of and regulatory strategies around 505(b)(2) NDA submissions.     
 
Gerald Sakowski, chief executive officer of CMP Pharma, said, “These two products are excellent complements to our line of niche specialty pharmaceutical products. This is another chapter in our long history of developing stable, ready-to-use liquid dosage forms that make life easier on the consumer, the physician and the pharmacist.”